Skip to main content
. Author manuscript; available in PMC: 2024 Sep 10.
Published in final edited form as: J Nucl Med. 2014 Dec 18;56(1):56–62. doi: 10.2967/jnumed.114.148106

TABLE 1.

t Test Statistics for K1 Values from 15O-Water and 62Cu-ETS for Normal Tissues and Metastatic Lesions

15O K1 vs. 62Cu K1 15O K1 62Cu K1 n P
All samples
 Baseline and therapy 0.55 ± 0.45 0.63 ± 0.42 88 0.28
 Baseline 0.66 ± 0.49 0.71 ± 0.43 42 0.65
 Treatment 0.45 ± 0.36 0.55 ± 0.38 46 0.25
Normal tissues
 Baseline and therapy 0.46 ± 0.42 0.54 ± 0.43 53 0.33
 Baseline 0.53 ± 0.42 0.58 ± 0.42 24 0.66
 Treatment 0.41 ± 0.42 0.51 ± 0.45 29 0.37
All lesions
 Baseline and therapy 0.69 ± 0.46 0.75 ± 0.38 35 0.56
 Baseline 0.84 ± 0.53 0.87 ± 0.40 18 0.81
 Treatment 0.53 ± 0.33 0.61 ± 0.32 17 0.47
Muscle
 Baseline and therapy 0.05 ± 0.04 0.10 ± 0.05 18 0.00011
 Baseline 0.05 ± 0.04 0.11 ± 0.02  8 0.0034
 Treatment 0.05 ± 0.04 0.10 ± 0.06 10 0.072
Thyroid
 Baseline and therapy 0.46 ± 0.25 0.54 ± 0.22 17 0.36
 Baseline 0.61 ± 0.19 0.69 ± 0.24  8 0.79
 Treatment 0.30 ± 0.17 0.41 ± 0.12  9 0.12
Myocardium
 Baseline and therapy 0.88 ± 0.35 0.99 ± 0.32 18 0.31
 Baseline 0.90 ± 0.32 0.97 ± 0.28  8 0.64
 Treatment 0.86 ± 0.39 1.00 ± 0.37 10 0.39